Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(21)00943-0
PubMed Identifier: 33964223
Publication URI: http://europepmc.org/abstract/MED/33964223
Type: Journal Article/Review
Volume: 397
Parent Publication: Lancet (London, England)
Issue: 10287
ISSN: 0140-6736